CONMED Corp — Director's Dealing 2017

Nov 9, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2017-11-07

Reporting Person: POMILIO LUKE A (EVP, Finance & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-07	Common Stock	S	1900	$50.82	Disposed	45486	Direct
2017-11-07	Common Stock	S	10529	$50.60	Disposed	34957	Direct
2017-11-08	Common Stock	S	12934	$50.77	Disposed	22023	Direct
2017-11-09	Common Stock	S	4000	$50.70	Disposed	18023	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.59 to $50.99. Full information regarding the number of shares sold at each separate price will be provided upon the request of the commission staff, ConMed, or a ConMed security holder.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.50 to $50.72. Full information regarding the number of shares sold at each separate price will be provided upon the request of the commission staff, ConMed, or a ConMed security holder.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.54 to $51.14. Full information regarding the number of shares sold at each separate price will be provided upon the request of the commission staff, ConMed, or a ConMed security holder.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.65 to $50.75. Full information regarding the number of shares sold at each separate price will be provided upon the request of the commission staff, ConMed, or a ConMed security holder.